Identifier | Name |
---|---|
R-ALL-9734123 | ARGX-111 [extracellular region] |
R-ALL-1248673 | Cetuximab [extracellular region] |
R-ALL-2077408 | FP-1039 [extracellular region] |
R-ALL-2067712 | GP369 [extracellular region] |
R-ALL-9680829 | His-Leu-lopinavir [extracellular region] |
R-ALL-9707824 | LCB1 [extracellular region] |
R-ALL-9707823 | LCB3 [extracellular region] |
R-ALL-9727112 | MRE-269 [extracellular region] |
R-ALL-9734076 | SAIT301 [extracellular region] |
R-ALL-9718414 | abarelix [extracellular region] |
R-ALL-9679474 | abicipar pegol [extracellular region] |
R-ALL-9714991 | adalimumab [extracellular region] |
R-ALL-9679475 | aflibercept [extracellular region] |
R-ALL-9728869 | albiglutide [extracellular region] |
R-ALL-9733378 | alirocumab [extracellular region] |
R-ALL-9707803 | alunacedase alfa [extracellular region] |
R-ALL-9681784 | anakinra [extracellular region] |
R-ALL-9724743 | aprotinin [extracellular region] |
R-ALL-9667607 | atosiban [extracellular region] |
R-ALL-9733136 | bamlanivimab [extracellular region] |
R-ALL-9679458 | bevacizumab [extracellular region] |
R-ALL-9603269 | bivalirudin [extracellular region] |
R-ALL-9679482 | brolucizumab [extracellular region] |
R-ALL-9718359 | buserelin [extracellular region] |
R-ALL-9679471 | camrelizumab [extracellular region] |
R-ALL-9679434 | cemiplimab [extracellular region] |
R-ALL-9714963 | certolizumab pegol [extracellular region] |
R-ALL-9718398 | cetrorelix [extracellular region] |
R-ALL-9709470 | darbepoetin alfa [extracellular region] |
R-ALL-9718373 | degarelix [extracellular region] |
R-ALL-9603260 | desirudin [extracellular region] |
R-ALL-9667393 | desmopressin [extracellular region] |
R-ALL-9728872 | dulaglutide [extracellular region] |
R-ALL-9691601 | eculizumab [extracellular region] |
R-ALL-9689691 | emapalumab [extracellular region] |
R-ALL-9734092 | emibetuzumab [extracellular region] |
R-ALL-9709455 | epoetin alfa [extracellular region] |
R-ALL-9709461 | epoetin beta [extracellular region] |
R-ALL-9709457 | epoetin theta [extracellular region] |
R-ALL-9709469 | epoetin zeta [extracellular region] |
R-ALL-9702337 | eptinezumab [extracellular region] |
R-ALL-9702842 | erenumab [extracellular region] |
R-ALL-9714949 | etanercept [extracellular region] |
R-ALL-9733131 | etesevimab [extracellular region] |
R-ALL-9733413 | evolocumab [extracellular region] |
R-ALL-9728652 | exendin-4 [extracellular region] |
R-ALL-9689689 | fontolizumab [extracellular region] |
R-ALL-9702389 | fremanezumab [extracellular region] |
R-ALL-9702360 | galcanezumab [extracellular region] |
R-ALL-9724536 | ganirelix [extracellular region] |
R-ALL-9714993 | golimumab [extracellular region] |
R-ALL-9724430 | goserelin [extracellular region] |
R-ALL-9724440 | histrelin [extracellular region] |
R-ALL-9714952 | infliximab [extracellular region] |
R-ALL-9681764 | isunakinra [extracellular region] |
© 2023 Reactome